These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11686610)

  • 41. Discovery of bisindolyl-substituted cycloalkane-anellated indoles as novel class of antibacterial agents against S. aureus and MRSA.
    El-Sayed MT; Suzen S; Altanlar N; Ohlsen K; Hilgeroth A
    Bioorg Med Chem Lett; 2016 Jan; 26(1):218-21. PubMed ID: 26590101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A combinatorial approach to the discovery of biocidal six-residue cyclic D,L-alpha-peptides against the bacteria methicillin-resistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta.
    Fletcher JT; Finlay JA; Callow ME; Callow JA; Ghadiri MR
    Chemistry; 2007; 13(14):4008-13. PubMed ID: 17304598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solution-phase parallel synthesis of novel membrane-targeted antibiotics.
    Vooturi SK; Firestine SM
    J Comb Chem; 2010; 12(1):151-60. PubMed ID: 19928911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New bromotyrosine derivatives from an association of two sponges, Jaspis wondoensis and Poecillastra wondoensis.
    Park Y; Liu Y; Hong J; Lee CO; Cho H; Kim DK; Im KS; Jung JH
    J Nat Prod; 2003 Nov; 66(11):1495-8. PubMed ID: 14640526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.
    Göker H; Ozden S; Yildiz S; Boykin DW
    Eur J Med Chem; 2005 Oct; 40(10):1062-9. PubMed ID: 15992965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibacterial action of anacardic acids against methicillin resistant Staphylococcus aureus (MRSA).
    Kubo I; Nihei K; Tsujimoto K
    J Agric Food Chem; 2003 Dec; 51(26):7624-8. PubMed ID: 14664518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives.
    Hoemann MZ; Xie RL; Rossi RF; Meyer S; Sidhu A; Cuny GD; Hauske JR
    Bioorg Med Chem Lett; 2002 Jan; 12(2):129-32. PubMed ID: 11755337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
    Zhang WM; Yao Y; Yang T; Wang XY; Zhu ZY; Xu WT; Lin HX; Gao ZB; Zhou H; Yang CG; Cui YM
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1943-1948. PubMed ID: 29650291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antimicrobial evaluation of TAN-1057A/B analogs.
    Williams RM; Yuan C; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 1998 Feb; 51(2):189-201. PubMed ID: 9544941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.
    Kerns RJ; Rybak MJ; Kaatz GW; Vaka F; Cha R; Grucz RG; Diwadkar VU; Ward TD
    Bioorg Med Chem Lett; 2003 May; 13(10):1745-9. PubMed ID: 12729656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
    Hiraiwa Y; Minowa N; Usui T; Akiyama Y; Maebashi K; Ikeda D
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6369-72. PubMed ID: 17889537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity.
    Chen JP; Battini N; Ansari MF; Zhou CH
    Eur J Med Chem; 2021 May; 217():113340. PubMed ID: 33725630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
    J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.
    Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL
    J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
    Turos E; Revell KD; Ramaraju P; Gergeres DA; Greenhalgh K; Young A; Sathyanarayan N; Dickey S; Lim D; Alhamadsheh MM; Reynolds K
    Bioorg Med Chem; 2008 Jul; 16(13):6501-8. PubMed ID: 18524602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A xanthanolide with potent antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Sato Y; Oketani H; Yamada T; Singyouchi K; Ohtsubo T; Kihara M; Shibata H; Higuti T
    J Pharm Pharmacol; 1997 Oct; 49(10):1042-4. PubMed ID: 9364417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.
    Stiff C; Graber DR; Thorarensen A; Wakefield BD; Marotti KR; Melchior EP; Sweeney MT; Han F; Rohrer DC; Zurenko GE; Romero DL
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6293-7. PubMed ID: 18951783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
    Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase.
    Franci G; Folliero V; Cammarota M; Zannella C; Sarno F; Schiraldi C; de Lera AR; Altucci L; Galdiero M
    Sci Rep; 2018 Sep; 8(1):13117. PubMed ID: 30177735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.